Salirasib

DB12681InvestigationalSmall molecule

Salirasib has been used in trials studying the diagnostic of Carcinoma, Non-Small-Cell Lung.

Chemical structure of Salirasib
Formula / weight
C22H30O2S · 358.54 g/mol (avg)

Resolves to

Compound
UNIIMZH0OM550MCAS162520-00-5ChEMBLCHEMBL23293PubChem5469318
Structure
InChIKeyWUILNKCFCLNXOK-CFBAGHHKSA-NSMILESCC(C)=CCC\C(C)=C\CC\C(C)=C\CSC1=CC=CC=C1C(O)=O
Targets
P42345MTORP01111NRAS

What you can answer from here — as of January 29, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
39Drug interactionsStructured to mechanism, not free text
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Salirasib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In